sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Interest in Mural Oncology plc
The Vanguard Group, Inc. has submitted a Form 8.3 disclosure in compliance with the Irish Takeover Panel regulations. This disclosure reveals that The Vanguard Group holds a notable 4.48% interest in Mural Oncology plc, equivalent to 772,787 ordinary shares. The latest position was recorded on July 7, 2025.
The filing indicates no other parties are involved in this disclosure, and The Vanguard Group has not entered any other significant agreements or derivative positions concerning Mural Oncology plc. Additionally, The Vanguard Group reports a minor transaction involving the sale of 32 $0.01 ordinary shares at a price of 2.48 USD each.
No derivative transactions or other securities-related agreements are mentioned in the document, nor are there any supplemental forms attached to this disclosure.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.